News

Zbiotics introduces probiotic hangover cure

20 Aug 2019

ZBiotics, a genetic engineering company creating consumer products designed to augment health and improve everyday lives, has announced the official launch of ZBiotics, a functional beverage that contains a genetically engineered probiotic bacteria designed to break down acetaldehyde, an unwanted byproduct of alcohol that is associated with rough feelings the day after drinking.

The launch of ZBiotics is claimed to mark the first time this sophisticated level of biotechnology has been applied to probiotics. As a result, the company says it has pioneered a brand new category with ZBiotics, engineered to help improve people's natural ability to digest a byproduct of alcohol, and in so doing feel better the day after drinking.

Zbiotics introduces probiotic hangover cure

To create ZBiotics, company co-founder/CEO and microbiologist Zack Abbott started with a naturally occurring probiotic bacteria, then genetically engineered its DNA to replicate the natural process that takes place in the liver when alcohol is consumed: the production of an enzyme that breaks down acetaldehyde.

"Our environment and lifestyles have changed dramatically over the last few thousand years, and as it relates to biotechnology, we no longer have to wait for the next few hundred-thousand years for our anatomy to catch up. That's why we've created a purpose-built, enhanced probiotic beverage designed to augment the capabilities of your gut," said Abbott. "It goes beyond mixing together vitamins and root extracts and hoping for the best. We are a science-forward company that starts with the problem – in this case, the microbiome's natural inability to break down acetaldehyde – and builds a specific solution. It is genetic engineering as it should be: working for you, with effectiveness you can feel for yourself."

Founded in 2016, ZBiotics says it is thoughtfully positioned at the forefront of the "GMO 2.0" movement, inventing game-changing consumer products using sophisticated bioengineering techniques in a responsible, transparent, and accessible manner. It is, the company claims, a new type of genetic engineering company: one that puts people first and that shares clear, detailed information about their technology, their intentions, and their mission to educate and empower consumers to make their own informed decisions about GMOs.

ZBiotics is said to be the result of years of rigorous research and testing, and provides a novel solution never before possible. But this first product is just the beginning, the company says: the team is already working on building other novel solutions using the same technology.

"Whether they are promoting increased levels of nutrient absorption or helping break down environmental toxins, the enhanced probiotics we are building will provide consumers with new health-promoting functionalities that are only possible thanks to genetic engineering," said Abbott. "We are thrilled for people to try our first product and excited to continue in our efforts to solve even more intractable problems with this incredible technology."

Related news

Our most-read articles of 2025

Our most-read articles of 2025

23 Dec 2025

From trade tariffs to heavy metals in protein, we look back at some of the industry’s highlights of 2025 and round up our most-read stories of the year.

Read more 
Bigging up bean-based products and consumption in Britain

Bigging up bean-based products and consumption in Britain

19 Dec 2025

Non-profit organisation the Food Foundation has launched a campaign, “Bang in Some Beans”, designed to increase UK consumers’ legume consumption.

Read more 
Ingredient transparency key to success in European natural health market

Ingredient transparency key to success in European natural health market

12 Dec 2025

Europe’s $40.7 billion supplements market is growing fast, fuelled by demand for products that support healthy ageing, mental wellbeing, and preventive health, say experts.

Read more 
Whole Foods Market forecasts fibre frenzy for 2026

Whole Foods Market forecasts fibre frenzy for 2026

11 Dec 2025

Whole Foods Market has released its top 2026 trends, predicting that a fibre frenzy will take place next year as health-conscious consumers seek out nutritious, filling options.

Read more 
Sorghum emerges as better-for-you hero ingredient

Sorghum emerges as better-for-you hero ingredient

9 Dec 2025

With the launch of Novak Djokovic’s sorghum-based brand, the grain’s popularity in the better-for-you snacking sphere is on the rise, thanks to its nutritional and sensory properties.

Read more 
Innovation promise in 'maturing' plant-based dairy alternatives market

Innovation promise in 'maturing' plant-based dairy alternatives market

8 Dec 2025

Plant-based dairy is a maturing market that still faces significant hurdles around taste, functionality, nutrition, and price, but industry is innovating fast, according to experts speaking at Fi Europe.

Read more 
Celebrating the winners of the Fi Europe Innovation Awards 2025

Celebrating the winners of the Fi Europe Innovation Awards 2025

3 Dec 2025

Food industry stakeholders celebrated as the winners of the Fi Europe Innovation Awards were announced at a ceremony in Paris.

Read more 
Apply now for the Vitafoods Europe Innovation Awards 2026!

Apply now for the Vitafoods Europe Innovation Awards 2026!

28 Nov 2025

Entries for the Vitafoods Europe Innovation Awards 2026 are now open! Game-changing companies have until 27 February to submit their entry across eight categories for the chance to win big.

Read more 
Concerns swirl around cinnamon’s compliance with EU law

Concerns swirl around cinnamon’s compliance with EU law

25 Nov 2025

Cinnamon may be a top functional ingredient, but it needs stronger protocols to ensure it meets EU food safety laws and quality standards, say researchers.

Read more 
Bone broth: From old-fashioned to en vogue

Bone broth: From old-fashioned to en vogue

24 Nov 2025

OXO’s entry into bone broth has turned the spotlight on this small but high-performance category – and there is still scope for growth, especially in the area of GLP-1 support.

Read more